JP MORGAN/CALL/BECTON DICKINSON AND CO./255/0.1/17.01.25 Share Price

Warrant

DE000JL1KNT5

Market Closed - Börse Stuttgart 08:21:32 20/06/2024 BST
1.63 EUR +1.24% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./255/0.1/17.01.25
Current month+18.38%
1 month-14.81%
Date Price Change
20/06/24 1.63 +1.24%
19/06/24 1.61 +0.63%
18/06/24 1.6 -3.03%
17/06/24 1.65 +10.00%
14/06/24 1.5 -7.41%

Delayed Quote Börse Stuttgart

Last update June 20, 2024 at 08:21 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNT
ISINDE000JL1KNT5
Date issued 05/04/2023
Strike 255 $
Maturity 17/01/2025 (211 Days)
Parity 10 : 1
Emission price 3.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.43
Lowest since issue 1.18
Spread 0.15
Spread %7.46%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.4 USD
Average target price
279.2 USD
Spread / Average Target
+17.11%
Consensus